Aprepitant
| CAS No. | 170729-80-3 |
|---|---|
| MDL No. | MFCD08277635 |
| MF | C23H21F7N4O3 |
| MW | 534.40 |
| InChI Key | ATALOFNDEOCMKK-OITMNORJSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Aprepitant is a morpholine-based antiemetic used for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. It is a selective, high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. It functions as an antidepressant, antiemetic, peripheral nervous system drug, neurokinin-1 receptor antagonist, and substance P receptor antagonist. It belongs to triazoles, morpholines, cyclic acetals, and (trifluoromethyl)benzenes.
| CAS No. | 170729-80-3 |
|---|---|
| Product Name | Aprepitant |
Biological Targets
TACR1
Associated Conditions
Chemotherapy-induced nausea and vomiting·opioid dependence·cocaine dependence·germ cell tumor·COVID-19·
* The information provided here is compiled from public sources and is for reference only.
